Literature DB >> 2406179

Type 1 (insulin-dependent) diabetes mellitus diagnosed during pregnancy: a clinical and prognostic study.

K Buschard1, P Hougaard, L Mølsted-Pedersen, C Kühl.   

Abstract

The study concerns the clinical outcome and later prognosis (regarding permanent insulin treatment) of patients who develop insulin-dependent diabetes mellitus during pregnancy (which is different from gestational diabetes). Sixty-three such patients (27 +/- 1 (SEM) years old) were delivered at the Copenhagen Centre for Diabetes and Pregnancy during the years 1966-1980. Obstetric complications such as toxaemia were seen in 9.5% of these study patients and the perinatal mortality was 6.3%, both percentages being higher than in the general population (1.1%, p less than 10(-7) and 1.0%, p less than 10(-3), respectively), but similar to those observed in patients with Type 1 diabetes diagnosed before pregnancy. In contrast, the frequency of malformations was 1.6%, the same as in the general population (1.4%), but lower than that seen in patients with long-standing diabetes (8.3%, p less than 0.05). At follow-up examination 8 +/- 1 years after diagnosis all patients were diabetic; 77% were insulin treated, having no or virtually no residual B-cell function, and were clearly Type 1 diabetic patients. After delivery 80% of the patients had a remission period (median 256 days) without insulin treatment. This remission period was absent or shortest in patients with the following characteristics (p less than or equal to 0.03): low age, first parity, not overweight, and high blood glucose level at diagnosis. These prognostic parameters should be considered in obligatory, clinical follow-up plans for such patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2406179     DOI: 10.1007/bf00586458

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  8 in total

1.  C-peptide in children with juvenile diabetes. A preliminary report.

Authors:  J Ludvigsson; L G Heding
Journal:  Diabetologia       Date:  1976-12       Impact factor: 10.122

2.  Increased incidence of true type I diabetes acquired during pregnancy.

Authors:  K Buschard; I Buch; L Mølsted-Pedersen; P Hougaard; C Kühl
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-31

3.  Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study.

Authors:  J A Goldman; D Dicker; D Feldberg; A Yeshaya; N Samuel; M Karp
Journal:  Am J Obstet Gynecol       Date:  1986-08       Impact factor: 8.661

4.  HLA associations in insulin-dependent diabetes mellitus diagnosed during pregnancy.

Authors:  B Møller-Jensen; K Buschard; I Buch; L Mølsted-Pedersen; C Kühl; B K Jakobsen; A Svejgaard
Journal:  Acta Endocrinol (Copenh)       Date:  1987-11

5.  Prevalence of residual beta-cell function in insulin-dependent diabetics in relation to age at onset and duration of diabetes.

Authors:  S Madsbad; O K Faber; C Binder; P McNair; C Christiansen; I Transbøl
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

6.  Prevention of congenital malformations in infants of insulin-dependent diabetic mothers.

Authors:  K Fuhrmann; H Reiher; K Semmler; F Fischer; M Fischer; E Glöckner
Journal:  Diabetes Care       Date:  1983 May-Jun       Impact factor: 19.112

7.  Meal-stimulated C-peptide and insulin antibodies in type I diabetic subjects and their nondiabetic siblings characterized by HLA-DR antigens.

Authors:  B J Hoogwerf; S S Rich; J J Barbosa
Journal:  Diabetes       Date:  1985-05       Impact factor: 9.461

8.  Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

Authors:  S Madsbad; T Krarup; P McNair; C Christiansen; O K Faber; I Transbøl; C Binder
Journal:  Acta Med Scand       Date:  1981
  8 in total
  1 in total

1.  The influence of maternal islet beta-cell autoantibodies in conjunction with gestational hyperglycemia on neonatal outcomes.

Authors:  Zhe Li; Tian-mei Wu; Wei-jie Ming; Xin Chen; Xiao-min Xiao
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.